It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Introduction
Major salivary gland ultrasonography (SGUS) demonstrated its good metric properties as an outcome measure for diagnosing primary Sjögren’s disease (SD). The objective was to assess SGUS reliability among sonographers with different levels of experience, using web training.
Methods
Sonographers from expert centers participated in the reliability exercise. Before exercises, training was done by videoconferencing. Reliability of the two most experienced sonographers (MES) was assessed and then compared to other sonographers. Intra-reader and inter-reader reliability of SGUS items were assessed by computing Cohen’s κ coefficients.
Results
All sets were read twice by all 14 sonographers within a 4-month interval. Intra-reader reliability of MES was almost perfect for homogeneity, substantial for Outcome Measures in Rheumatology (OMERACT) scoring system (OMERACTss). Among LES (less experienced sonographers), reliability was moderate to almost perfect for homogeneity, fair to moderate for OMERACTss, and fair to almost perfect for binary OMERACTss. Inter-reader reliability between MES was almost perfect for homogeneity, substantial for diagnosis, moderate for OMERACTss, and substantial for binary OMERACTss. Compared to MES, reliabilities of LES were moderate to almost perfect for both homogeneity and diagnosis, only fair to moderate for OMERACTss, but increased in binary OMERACTss.
Conclusions
Videoconferencing training sessions in an international reliability exercise could be an excellent tool to train experienced and less-experienced sonographers. SGUS homogeneity items is useful to distinguish normal from abnormal salivary glands parenchyma independently of diagnosis. Structural damage evaluations by OMERACT scoring system is a new comprehensive score to diagnose patients with SD and could be easily used by sonographers in a binary method.
Plain Language Summary
The goal of this project was to evaluate the reliability of salivary gland ultrasonography in patients with Sjögren’s disease using online training in an international study. Currently, salivary gland ultrasonography is routinely used only by European expert sonographers but few studies have studied intra-reader and inter-reader reliability, among less experienced international sonographers. Many salivary gland ultrasonography scoring systems are used today, but it is difficult to know how to put them into practice. Online training on an international level allows a significant number of practitioners to use the different scoring systems including the latest OMERACT (Outcome Measures in Rheumatology) score, which is simple and comprehensive. There were two phases to this project: A first step consisted in a training session by videoconferencing to all sonographers, the second step was an inter and intra-reader reliability exercises. The results of our study showed satisfactory results, especially for parenchyma homogeneity. Regarding the comprehensive OMERACT score, the results are quite disparate, notably for less experienced sonographers and could be explained by this new comprehensive scoring system. However, when binary OMERACT score (minor damage versus major damage of salivary gland parenchyma (OMERACT score 0–1 vs. 2–3) was employed, reliability increased and can be very useful for novice sonographers in routine practice because it does not require scoring of all the pathological features in Sjögren’s disease. This study highlights the need to train non-experts interested in this field and demonstrates the potential for beginners to quickly become experts.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 CHU Hospital La Cavale-Blanche, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINO), Rheumatology Department, Brest, France; Univ Brest, Inserm, LBAI, UMR1227, Brest, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389)
2 CHU Hospital La Cavale-Blanche, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINO), Rheumatology Department, Brest, France (GRID:grid.7429.8); Univ Brest, Inserm, LBAI, UMR1227, Brest, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389); CHRU Cavale Blanche, Boulevard Tanguy Prigent, Service de Rhumatologie, Brest, France (GRID:grid.7429.8)
3 Hospital, CHU Trousseau Tours, Rheumatology Department, Chambray-lès-Tours, France (GRID:grid.411167.4) (ISNI:0000 0004 1765 1600)
4 CHU Hospital La Cavale-Blanche, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINO), Rheumatology Department, Brest, France (GRID:grid.411167.4); CIC INSERM 1412, Brest, France (GRID:grid.488479.e)
5 CHU Montpellier, Montpellier University, Rheumatology Department and IDESP, Montpellier, France (GRID:grid.157868.5) (ISNI:0000 0000 9961 060X)
6 Hospital Huriez, Internal Medicine Department, Lille, France (GRID:grid.157868.5)
7 Haukeland University Hospital, Department of Rheumatology, Bergen, Norway (GRID:grid.412008.f) (ISNI:0000 0000 9753 1393); University of Bergen, Broegelmann Research Laboratory, Bergen, Norway (GRID:grid.7914.b) (ISNI:0000 0004 1936 7443)
8 University of Bergen, Department of Clinical Dentistry-Section for Oral and Maxillofacial Radiology, Bergen, Norway (GRID:grid.7914.b) (ISNI:0000 0004 1936 7443)
9 Chonnam National University Bitgoeul Hospital, Gwangju, South Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399)
10 Konkuk University Medical Center, Division of Rheumatology, Department of Internal Medicine, Seoul, Korea (GRID:grid.411120.7) (ISNI:0000 0004 0371 843X)
11 UMCG, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598)
12 University Hospitals Birmingham NHS Foundation Trust, National Institute of Health Biomedical Research Centre and Department of Rheumatology, Birmingham, UK (GRID:grid.412563.7) (ISNI:0000 0004 0376 6589); University of Birmingham, Institute of Inflammation and Ageing, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
13 Technical University of Munich, Department of Otorhinolaryngology/Head and Neck Surgery, Klinikum rechts der Isar, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
14 University of Pisa, Rheumatology Unit, Department of Clinical and Experimental Medicine, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729)
15 University of Belgrade, Institute of Rheumatology, Faculty of Medicine, Beograd, Serbia (GRID:grid.7149.b) (ISNI:0000 0001 2166 9385)
16 Johns Hopkins University, Division of Rheumatology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
17 CHU Hospital La Cavale-Blanche, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINO), Rheumatology Department, Brest, France (GRID:grid.21107.35); Univ Brest, Inserm, LBAI, UMR1227, Brest, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389)
18 CHU Hospital La Cavale-Blanche, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINO), Rheumatology Department, Brest, France (GRID:grid.7429.8); Univ Brest, Inserm, LBAI, UMR1227, Brest, France (GRID:grid.7429.8) (ISNI:0000 0001 2186 6389)